Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Blueprint Medicines Corp | CHIEF EXECUTIVE OFFICER | Common Stock | 153K | $13.9M | $90.69 | Mar 7, 2024 | Direct |
Blueprint Medicines Corp | CHIEF EXECUTIVE OFFICER | Stock Option (Right to Buy) | 80K | Mar 1, 2024 | Direct | ||
Fulcrum Therapeutics, Inc. | Director | Stock Option (right to buy) | 30K | Jun 17, 2024 | Direct | ||
Bicara Therapeutics Inc. | Director | Stock Option (Right to Buy) | 23.7K | Sep 12, 2024 | Direct | ||
Bicara Therapeutics Inc. | Director | Common Stock | 7.44K | Sep 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BCAX | Bicara Therapeutics Inc. | Sep 12, 2024 | 1 | $0 | 4 | Sep 16, 2024 | Director |
BCAX | Bicara Therapeutics Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | Director |
FULC | Fulcrum Therapeutics, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
BPMC | Blueprint Medicines Corp | Mar 7, 2024 | 1 | -$1.13M | 4 | Mar 11, 2024 | CHIEF EXECUTIVE OFFICER |
BPMC | Blueprint Medicines Corp | Mar 1, 2024 | 2 | $0 | 4 | Mar 6, 2024 | CHIEF EXECUTIVE OFFICER |
FULC | Fulcrum Therapeutics, Inc. | Jun 27, 2023 | 1 | $0 | 4 | Jun 29, 2023 | Director |
BPMC | Blueprint Medicines Corp | Mar 6, 2023 | 2 | -$303K | 4 | Mar 8, 2023 | CHIEF EXECUTIVE OFFICER |
BPMC | Blueprint Medicines Corp | Mar 1, 2023 | 2 | $0 | 4 | Mar 3, 2023 | CHIEF EXECUTIVE OFFICER |
BPMC | Blueprint Medicines Corp | Nov 3, 2022 | 1 | $48.4K | 4 | Nov 7, 2022 | CHIEF EXECUTIVE OFFICER |
FULC | Fulcrum Therapeutics, Inc. | Jun 27, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Director |
BPMC | Blueprint Medicines Corp | Mar 3, 2022 | 2 | -$162K | 4 | Mar 8, 2022 | CHIEF OPERATING OFFICER |
BPMC | Blueprint Medicines Corp | Mar 1, 2022 | 2 | $0 | 4 | Mar 3, 2022 | CHIEF OPERATING OFFICER |
BPMC | Blueprint Medicines Corp | Dec 13, 2021 | 6 | -$62.2K | 4 | Dec 15, 2021 | Chief Operating Officer |
BPMC | Blueprint Medicines Corp | Sep 13, 2021 | 7 | -$63.9K | 4 | Sep 15, 2021 | Chief Operating Officer |
BPMC | Blueprint Medicines Corp | Jun 28, 2021 | 5 | -$54.2K | 4 | Jun 30, 2021 | Chief Operating Officer |
FULC | Fulcrum Therapeutics, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |